Wide Ranks

ISRG

Intuitive Surgical, Inc.

538.55

Top Statistics
Market Cap 191 B Forward PE 68.81 Revenue Growth 16.90 %
Current Ratio 4.30 Trailing PE 87.00 Earnings Growth 34.50 %
Profit Margins 28.51 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 74.92 Enterprise / Revenue 23.86 Price To Sales Trailing12 Months 24.38
Profitability
Profit Margins 28.51 % Operating Margins 28.32 %
Balance Sheet
Total Cash 4 B Total Cash Per Share 11.88 Total Debt
Total Debt To Equity Current Ratio 4.30 Book Value Per Share 43.75
All Measures
Short Ratio 292.00 % Message Board Id finmb_30239 Fax 408 523 1390
Shares Short Prior Month 3 M Return On Equity 0.1597 City Sunnyvale
Uuid fae970d5-82c8-3b4b-a1eb-c4a07c93573d Previous Close 542.10 First Trade Date Epoch Utc 961 M
Book Value 43.75 Beta 1.39 Volume 937574
Price To Book 12.31 Last Split Date 1 B Fifty Two Week Low 304.50
Total Cash Per Share 11.88 Total Revenue 7 B Shares Short Previous Month Date 1 B
Target Median Price 550.00 Max Age 86400 Recommendation Mean 1.90
Sand P52 Week Change 0.3133 Operating Margins 28.32 % Target Mean Price 536.43
Net Income To Common 2 B Short Percent Of Float 0.0117 Implied Shares Outstanding 356 M
Trailing Peg Ratio 399.37 % Last Fiscal Year End 1 B Average Daily Volume10 Day 1 M
Average Volume10days 1 M Total Cash 4 B Next Fiscal Year End 1 B
Revenue Per Share 22.22 Held Percent Insiders 0.0052 Ebitda Margins 31.84 %
Trailing PE 87.00 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 542.10 Target Low Price 265.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 507.94 Open 543.08 Free Cashflow 637 M
State CA Dividend Yield 0.00 % Return On Assets 0.0795
Time Zone Short Name EST Trailing Eps 6.19 Day Low 538.23
Address1 1020 Kifer Road Shares Outstanding 356 M Price Hint 2
Target High Price 643.00 Website https://www.intuitive.com 52 Week Change 0.7326
Average Volume 1 M Earnings Quarterly Growth 35.90 % Forward Eps 7.86
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 329.30 %
Last Split Factor 3:1 Regular Market Day High 543.97 Is_sp_500 True
Profit Margins 28.51 % Fifty Two Week High 552.00 Day High 543.97
Shares Short 4 M Regular Market Open 543.08 Industry Key medical-instruments-supplies
Earnings Growth 34.50 % Enterprise To Revenue 23.86 Revenue Growth 16.90 %
Shares Percent Shares Out 0.0117 Operating Cashflow 1 B Currency USD
Time Zone Full Name America/New_York Market Cap 191 B Is_nasdaq_100 True
Zip 94086-5304 Quote Type EQUITY Industry Medical Instruments & Supplies
Long Name Intuitive Surgical, Inc. Regular Market Day Low 538.23 Held Percent Institutions 0.8915
Current Price 538.55 Enterprise To Ebitda 74.92 Financial Currency USD
Current Ratio 4.30 Gross Margins 66.98 % Industry Disp Medical Instruments & Supplies
Number Of Analyst Opinions 26 Country United States Float Shares 354 M
Two Hundred Day Average 442.28 Ir Website http://investor.intuitivesurgical.com/phoenix.zhtml?c=122359&p=irol-IRHome Enterprise Value 187 B
Price To Sales Trailing12 Months 24.38 Forward PE 68.81 Regular Market Volume 937574
Ebitda 2 B Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.

The company sells its products through direct sales organizations, such as capital and clinical sales teams.

It has a collaboration agreement with FluoGuide A/S for head & neck cancer.

The company was incorporated in 1995 and is headquartered in Sunnyvale, California.